The Vigabatrin REMS Program is needed by the FDA to make certain notified risk-benefit decisions prior to initiating treatment, and to ensure suitable use vigabatrin while people are treated. It is not feasible for your healthcare provider to know when vision loss will occur.
It is recommended that your healthcare provider test your (or your child's) vision before or within 4 weeks after starting SABRIL and at the very least every 3 months during treatment till SABRIL is quit. Inform your doctor if you or your youngster have any negative effects that troubles you or that does not vanish.
Tell your healthcare provider if you are pregnant or mean to get pregnant. If vision testing can not be done, your healthcare provider may continue prescribing SABRIL, however will not be able to look for any kind of vision loss. If vision examinations are refrained from doing regularly, your healthcare provider might stop prescribing SABRIL for you (or your child).